Skip to main content

ABI, Affy, GE, NIAID Among Eight Groups to Act as ERCC RNAi Testing Sites

NEW YORK (GenomeWeb News) – The External RNA Controls Consortium today said that eight testing sites have registered for the initial phase of the RNA control testing initiative.
The participants are: Affymetrix, Agilent, Applied Biosystems, GE Healthcare, Illumina, National Institute of Allergy and Infectious Diseases, Qiagen, and Roche Molecular Systems.
The ERCC said it will be accepting applications for other non-manufacturing or non-production sites for control testing in different types of biological samples later this year.
Founded in 2003, the ERCC is an ad-hoc group with approximately 200 members from more than 65 private, public, and academic organizations that aims to develop a set of external RNA controls, related protocols, and analysis tools.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.